How Value-based Solutions Can Improve Costs and Health Outcomes for Chronic Conditions
Over 125 million Americans suffer from chronic conditions, costing the U.S. over $3.4 trillion annually. This topic was the focus of a breakout session at Outcomes+ 2022.
Read MoreUse of Smoking Cessation Medications Significantly Decline Amid Pandemic
Data suggests employers and health plans need a renewed focus on tobacco use interventions.
Read MoreEvernorth and Behavioral Health Center of Excellence Collaborate to Measure Health Outcomes for Autism Treatment
First-of-its-kind partnership will establish quality performance metrics to drive improvements in quality of therapy for autism spectrum disorder
Read MoreEvernorth and Kaiser Permanente Enter Strategic Collaboration to Deliver More Convenient, Affordable and Accessible Health Care
Broad agreement aims to increase convenience and expand affordable access to valuable health benefits and high-quality care to millions more Americans Kaiser Permanente members will benefit from ac...
Read MoreWhat Is Drug Trend and How to Manage it
Drug trend, a good annual barometer for plan sponsor who are looking to control traditional and specialty drug costs, can and should be managed to improve medication access. This topic was the foc...
Read MoreThree specialty drug trends to prepare for: Biosimilars, gene and cell therapies, cancer drugs
Biosimilars, gene and cell therapies, and cancer drugs are filling the specialty pipeline. Here are some insights for each category to help you stay informed. This topic was the focus of a breakout...
Read More